Literature DB >> 10786670

Alterations of the INK4a/ARF locus in human intracranial germ cell tumors.

M Iwato1, O Tachibana, Y Tohma, Y Arakawa, H Nitta, M Hasegawa, J Yamashita, Y Hayashi.   

Abstract

Little is known about the molecular mechanisms responsible for the development of intracranial germ cell tumors (ICGTs). Recently, we demonstrated that the balance of the p53-mdm2 interactions is disrupted in ICGTs. The p14ARF product, a tumor suppresser gene located on the INK4a/ARF locus, acts as one of the major factors affecting p53-mdm2 interactions via its binding to mdm2 and the stimulation of mdm2 degradation. To evaluate whether genetic alterations of the INK4a/ARF locus occur in the genesis of ICGTs, we analyzed the INK4a/ARF genes in 21 ICGTs-10 pure germinomas and 11 nongerminomatous germ cell tumors. Fifteen (71%) of the 21 ICGTs displayed genetic alterations, including 14 homozygous deletions and 1 frameshift mutation. Furthermore, the frequency of the alterations was higher in pure germinomas [9 (90%) of the 10] than in nongerminomatous germ cell tumors [6 (55%) of the 11; P = 0.09]. These data suggested that INK4a/ARF gene abnormalities could play an important role in the genesis of ICGTs, especially in pure germinoma.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10786670

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  12 in total

1.  Homozygous deletion of INK4a/ARF genes and overexpression of bcl-2 in relation with poor prognosis in immunocompetent patients with primary central nervous system lymphoma of the diffuse large B-cell type.

Authors:  Y Hayashi; M Iwato; Y Arakawa; H Fujisawa; Y Thoma; M Hasegawa; O Tachibana; J Yamashita
Journal:  J Neurooncol       Date:  2001-10       Impact factor: 4.130

2.  p53 inactivation by MDM2 and MDMX negative feedback loops in testicular germ cell tumors.

Authors:  Baozong Li; Qian Cheng; Zhenyu Li; Jiandong Chen
Journal:  Cell Cycle       Date:  2010-04-01       Impact factor: 4.534

3.  Intracranial germinomas in a father and his son.

Authors:  Kampei Shimizu; Yohei Mineharu; Hirotoshi Imamura; Katsunori Asai; Yukihiro Imai; Koichi Ichimura; Nobuyuki Sakai
Journal:  Childs Nerv Syst       Date:  2014-06-07       Impact factor: 1.475

4.  Constant p53 pathway inactivation in a large series of soft tissue sarcomas with complex genetics.

Authors:  Gaëlle Pérot; Frédéric Chibon; Audrey Montero; Pauline Lagarde; Hugues de Thé; Philippe Terrier; Louis Guillou; Dominique Ranchère; Jean-Michel Coindre; Alain Aurias
Journal:  Am J Pathol       Date:  2010-10       Impact factor: 4.307

5.  Mixed testicular germ cell tumour in a patient with previous pineal germinoma.

Authors:  Vanessa B Silva; Ana L Azevedo; Ilda M Costa; Manuela S Mafra; José L Passos-Coelho; José M Bravo-Marques
Journal:  J Neurooncol       Date:  2010-05-12       Impact factor: 4.130

Review 6.  Molecular genetics of pineal region neoplasms.

Authors:  M D Taylor; T G Mainprize; J A Squire; J T Rutka
Journal:  J Neurooncol       Date:  2001-09       Impact factor: 4.130

Review 7.  Molecular markers in pediatric neuro-oncology.

Authors:  Koichi Ichimura; Ryo Nishikawa; Masao Matsutani
Journal:  Neuro Oncol       Date:  2012-09       Impact factor: 12.300

Review 8.  Therapeutic targets in the ARF tumor suppressor pathway.

Authors:  Anthony J Saporita; Leonard B Maggi; Anthony J Apicelli; Jason D Weber
Journal:  Curr Med Chem       Date:  2007       Impact factor: 4.530

9.  Two distinct pathways of p16 gene inactivation in gallbladder cancer.

Authors:  Hiroyuki Tadokoro; Takako Shigihara; Tomomi Ikeda; Masaru Takase; Masafumi Suyama
Journal:  World J Gastroenterol       Date:  2007-12-21       Impact factor: 5.742

10.  Germinal GLT8D1, GATAD2A and SLC25A39 mutations in a patient with a glomangiopericytal tumor and five different sarcomas over a 10-year period.

Authors:  Arnaud Beddok; Gaëlle Pérot; Sophie Le Guellec; Noémie Thebault; Alexandre Coutte; Henri Sevestre; Bruno Chauffert; Frédéric Chibon
Journal:  Sci Rep       Date:  2021-05-07       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.